Evergrande Health pays US$930 million to buy control of carmaker in its foray into mass production of electric vehicles in China โ€“ SCMP

What happened: Evergrande Health has purchased a 51% stake in electric vehicle manufacturer National Electric Vehicle Sweden (NEVS), marking its second foray into the electric car industry. The $930 million deal saw the company pay $430 million on Tuesday with the balance due by the end of the month. NEVS is Chinese consortium is owned by the municipal government of Tianjinโ€”a city in northern China, among others.

Why itโ€™s important: NEVS already has two vehicles that meet standards for mass production in China. The investment bolsters Evergrandeโ€™s plans to diversify its business to include electric vehicles, a move that hasnโ€™t been without difficulties. Evergrande Health recently resolved a spat with Faraday Future, another electric vehicle company in which it has invested. The months-long conflict, which included arbitration in Hong Kong, came to an end after it agreed to restructure its pledge to the electric vehicle maker.

Christopher Udemans is TechNode's former Shanghai-based data and graphics reporter. He covered Chinese artificial intelligence, mobility, cleantech, and cybersecurity.

Leave a comment

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.